ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastric Motility Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-31V12802
Home | Market Reports | Health| Health Conditions
Global Gastric Motility Drugs Market Research Report 2023
BUY CHAPTERS

Global Gastric Motility Drugs Market Research Report 2025

Code: QYRE-Auto-31V12802
Report
May 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer Inc
TEVA
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Lunan Pharmaceutical Group Corporation
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Xian Janssen Pharmaceutical Ltd.
GrupoFarma
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Hansoh Pharmaceutical Group Company Limited
Disha Pharmaceutical Group Co., Ltd

Gastric Motility Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastric Motility Drugs Market

Gastric Motility Drugs Market

The global market for Gastric Motility Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastric Motility Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Motility Drugs.
The Gastric Motility Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastric Motility Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastric Motility Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastric Motility Drugs Market Report

Report Metric Details
Report Name Gastric Motility Drugs Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin, Sigma-Tau Group, Wilmington, Chengdu Kanghong Pharmaceutical Group Co.,Ltd, Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Shanghai Sine Pharmaceutical Laboratories Co., Ltd, Disha Pharmaceutical Group Co., Ltd, Xian Janssen Pharmaceutical Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastric Motility Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastric Motility Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gastric Motility Drugs Market report?

Ans: The main players in the Gastric Motility Drugs Market are Johnson & Johnson, Sumitomo Dainippon, Sanofi, Pfizer, Teva, GrupoFarma, Abbott, Kyowa Kirin, Sigma-Tau Group, Wilmington, Chengdu Kanghong Pharmaceutical Group Co.,Ltd, Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Shanghai Sine Pharmaceutical Laboratories Co., Ltd, Disha Pharmaceutical Group Co., Ltd, Xian Janssen Pharmaceutical Ltd

What are the Application segmentation covered in the Gastric Motility Drugs Market report?

Ans: The Applications covered in the Gastric Motility Drugs Market report are Chronic Gastritis, Reflux Esophagitis, Functional Dyspepsia, Others

What are the Type segmentation covered in the Gastric Motility Drugs Market report?

Ans: The Types covered in the Gastric Motility Drugs Market report are Monotherapy, Poly Pill

Recommended Reports

Gastrointestinal Drugs

Therapies & Treatments

Related Drug Markets

1 Gastric Motility Drugs Market Overview
1.1 Product Definition
1.2 Gastric Motility Drugs by Type
1.2.1 Global Gastric Motility Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monotherapy
1.2.3 Poly Pill
1.3 Gastric Motility Drugs by Application
1.3.1 Global Gastric Motility Drugs Market Value by Application (2024 VS 2031)
1.3.2 Chronic Gastritis
1.3.3 Reflux Esophagitis
1.3.4 Functional Dyspepsia
1.3.5 Others
1.4 Global Gastric Motility Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastric Motility Drugs Revenue 2020-2031
1.4.2 Global Gastric Motility Drugs Sales 2020-2031
1.4.3 Global Gastric Motility Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastric Motility Drugs Market Competition by Manufacturers
2.1 Global Gastric Motility Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastric Motility Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastric Motility Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastric Motility Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastric Motility Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastric Motility Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gastric Motility Drugs, Date of Enter into This Industry
2.8 Global Gastric Motility Drugs Market Competitive Situation and Trends
2.8.1 Global Gastric Motility Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastric Motility Drugs Players Market Share by Revenue
2.8.3 Global Gastric Motility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastric Motility Drugs Market Scenario by Region
3.1 Global Gastric Motility Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastric Motility Drugs Sales by Region: 2020-2031
3.2.1 Global Gastric Motility Drugs Sales by Region: 2020-2025
3.2.2 Global Gastric Motility Drugs Sales by Region: 2026-2031
3.3 Global Gastric Motility Drugs Revenue by Region: 2020-2031
3.3.1 Global Gastric Motility Drugs Revenue by Region: 2020-2025
3.3.2 Global Gastric Motility Drugs Revenue by Region: 2026-2031
3.4 North America Gastric Motility Drugs Market Facts & Figures by Country
3.4.1 North America Gastric Motility Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastric Motility Drugs Sales by Country (2020-2031)
3.4.3 North America Gastric Motility Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gastric Motility Drugs Market Facts & Figures by Country
3.5.1 Europe Gastric Motility Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastric Motility Drugs Sales by Country (2020-2031)
3.5.3 Europe Gastric Motility Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastric Motility Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gastric Motility Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastric Motility Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastric Motility Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gastric Motility Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastric Motility Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastric Motility Drugs Sales by Country (2020-2031)
3.7.3 Latin America Gastric Motility Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastric Motility Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastric Motility Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastric Motility Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastric Motility Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastric Motility Drugs Sales by Type (2020-2031)
4.1.1 Global Gastric Motility Drugs Sales by Type (2020-2025)
4.1.2 Global Gastric Motility Drugs Sales by Type (2026-2031)
4.1.3 Global Gastric Motility Drugs Sales Market Share by Type (2020-2031)
4.2 Global Gastric Motility Drugs Revenue by Type (2020-2031)
4.2.1 Global Gastric Motility Drugs Revenue by Type (2020-2025)
4.2.2 Global Gastric Motility Drugs Revenue by Type (2026-2031)
4.2.3 Global Gastric Motility Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Gastric Motility Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastric Motility Drugs Sales by Application (2020-2031)
5.1.1 Global Gastric Motility Drugs Sales by Application (2020-2025)
5.1.2 Global Gastric Motility Drugs Sales by Application (2026-2031)
5.1.3 Global Gastric Motility Drugs Sales Market Share by Application (2020-2031)
5.2 Global Gastric Motility Drugs Revenue by Application (2020-2031)
5.2.1 Global Gastric Motility Drugs Revenue by Application (2020-2025)
5.2.2 Global Gastric Motility Drugs Revenue by Application (2026-2031)
5.2.3 Global Gastric Motility Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Gastric Motility Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Gastric Motility Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Sumitomo Dainippon
6.2.1 Sumitomo Dainippon Company Information
6.2.2 Sumitomo Dainippon Description and Business Overview
6.2.3 Sumitomo Dainippon Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sumitomo Dainippon Gastric Motility Drugs Product Portfolio
6.2.5 Sumitomo Dainippon Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Gastric Motility Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Gastric Motility Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Gastric Motility Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 GrupoFarma
6.6.1 GrupoFarma Company Information
6.6.2 GrupoFarma Description and Business Overview
6.6.3 GrupoFarma Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GrupoFarma Gastric Motility Drugs Product Portfolio
6.6.5 GrupoFarma Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Gastric Motility Drugs Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Kyowa Kirin
6.8.1 Kyowa Kirin Company Information
6.8.2 Kyowa Kirin Description and Business Overview
6.8.3 Kyowa Kirin Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kyowa Kirin Gastric Motility Drugs Product Portfolio
6.8.5 Kyowa Kirin Recent Developments/Updates
6.9 Sigma-Tau Group
6.9.1 Sigma-Tau Group Company Information
6.9.2 Sigma-Tau Group Description and Business Overview
6.9.3 Sigma-Tau Group Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sigma-Tau Group Gastric Motility Drugs Product Portfolio
6.9.5 Sigma-Tau Group Recent Developments/Updates
6.10 Wilmington
6.10.1 Wilmington Company Information
6.10.2 Wilmington Description and Business Overview
6.10.3 Wilmington Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Wilmington Gastric Motility Drugs Product Portfolio
6.10.5 Wilmington Recent Developments/Updates
6.11 Chengdu Kanghong Pharmaceutical Group Co.,Ltd
6.11.1 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information
6.11.2 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Description and Business Overview
6.11.3 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Product Portfolio
6.11.5 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments/Updates
6.12 Lunan Pharmaceutical Group Corporation
6.12.1 Lunan Pharmaceutical Group Corporation Company Information
6.12.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
6.12.3 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Product Portfolio
6.12.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
6.13 Hansoh Pharmaceutical Group Company Limited
6.13.1 Hansoh Pharmaceutical Group Company Limited Company Information
6.13.2 Hansoh Pharmaceutical Group Company Limited Description and Business Overview
6.13.3 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Product Portfolio
6.13.5 Hansoh Pharmaceutical Group Company Limited Recent Developments/Updates
6.14 Shanghai Sine Pharmaceutical Laboratories Co., Ltd
6.14.1 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information
6.14.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Description and Business Overview
6.14.3 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Product Portfolio
6.14.5 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments/Updates
6.15 Disha Pharmaceutical Group Co., Ltd
6.15.1 Disha Pharmaceutical Group Co., Ltd Company Information
6.15.2 Disha Pharmaceutical Group Co., Ltd Description and Business Overview
6.15.3 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Product Portfolio
6.15.5 Disha Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.16 Xian Janssen Pharmaceutical Ltd
6.16.1 Xian Janssen Pharmaceutical Ltd Company Information
6.16.2 Xian Janssen Pharmaceutical Ltd Description and Business Overview
6.16.3 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Product Portfolio
6.16.5 Xian Janssen Pharmaceutical Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastric Motility Drugs Industry Chain Analysis
7.2 Gastric Motility Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastric Motility Drugs Production Mode & Process Analysis
7.4 Gastric Motility Drugs Sales and Marketing
7.4.1 Gastric Motility Drugs Sales Channels
7.4.2 Gastric Motility Drugs Distributors
7.5 Gastric Motility Drugs Customer Analysis
8 Gastric Motility Drugs Market Dynamics
8.1 Gastric Motility Drugs Industry Trends
8.2 Gastric Motility Drugs Market Drivers
8.3 Gastric Motility Drugs Market Challenges
8.4 Gastric Motility Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer Inc
TEVA
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Lunan Pharmaceutical Group Corporation
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Xian Janssen Pharmaceutical Ltd.
GrupoFarma
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Hansoh Pharmaceutical Group Company Limited
Disha Pharmaceutical Group Co., Ltd
List of Tables
 Table 1. Global Gastric Motility Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastric Motility Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastric Motility Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastric Motility Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gastric Motility Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastric Motility Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastric Motility Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastric Motility Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastric Motility Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastric Motility Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastric Motility Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Gastric Motility Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastric Motility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Motility Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastric Motility Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastric Motility Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gastric Motility Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Gastric Motility Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gastric Motility Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Gastric Motility Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastric Motility Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastric Motility Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastric Motility Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastric Motility Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastric Motility Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gastric Motility Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gastric Motility Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastric Motility Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastric Motility Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastric Motility Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gastric Motility Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gastric Motility Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastric Motility Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastric Motility Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastric Motility Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gastric Motility Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gastric Motility Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastric Motility Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastric Motility Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastric Motility Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gastric Motility Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gastric Motility Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastric Motility Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastric Motility Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastric Motility Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gastric Motility Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gastric Motility Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastric Motility Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastric Motility Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Gastric Motility Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Gastric Motility Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Gastric Motility Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Gastric Motility Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastric Motility Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastric Motility Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastric Motility Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastric Motility Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Gastric Motility Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Gastric Motility Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Gastric Motility Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Gastric Motility Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Gastric Motility Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Gastric Motility Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastric Motility Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastric Motility Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastric Motility Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastric Motility Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Gastric Motility Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Gastric Motility Drugs Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Sumitomo Dainippon Company Information
 Table 76. Sumitomo Dainippon Description and Business Overview
 Table 77. Sumitomo Dainippon Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sumitomo Dainippon Gastric Motility Drugs Product
 Table 79. Sumitomo Dainippon Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Gastric Motility Drugs Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Gastric Motility Drugs Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Gastric Motility Drugs Product
 Table 94. Teva Recent Developments/Updates
 Table 95. GrupoFarma Company Information
 Table 96. GrupoFarma Description and Business Overview
 Table 97. GrupoFarma Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GrupoFarma Gastric Motility Drugs Product
 Table 99. GrupoFarma Recent Developments/Updates
 Table 100. Abbott Company Information
 Table 101. Abbott Description and Business Overview
 Table 102. Abbott Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Abbott Gastric Motility Drugs Product
 Table 104. Abbott Recent Developments/Updates
 Table 105. Kyowa Kirin Company Information
 Table 106. Kyowa Kirin Description and Business Overview
 Table 107. Kyowa Kirin Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Kyowa Kirin Gastric Motility Drugs Product
 Table 109. Kyowa Kirin Recent Developments/Updates
 Table 110. Sigma-Tau Group Company Information
 Table 111. Sigma-Tau Group Description and Business Overview
 Table 112. Sigma-Tau Group Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sigma-Tau Group Gastric Motility Drugs Product
 Table 114. Sigma-Tau Group Recent Developments/Updates
 Table 115. Wilmington Company Information
 Table 116. Wilmington Description and Business Overview
 Table 117. Wilmington Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Wilmington Gastric Motility Drugs Product
 Table 119. Wilmington Recent Developments/Updates
 Table 120. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information
 Table 121. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Description and Business Overview
 Table 122. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Product
 Table 124. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments/Updates
 Table 125. Lunan Pharmaceutical Group Corporation Company Information
 Table 126. Lunan Pharmaceutical Group Corporation Description and Business Overview
 Table 127. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Product
 Table 129. Lunan Pharmaceutical Group Corporation Recent Developments/Updates
 Table 130. Hansoh Pharmaceutical Group Company Limited Company Information
 Table 131. Hansoh Pharmaceutical Group Company Limited Description and Business Overview
 Table 132. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Product
 Table 134. Hansoh Pharmaceutical Group Company Limited Recent Developments/Updates
 Table 135. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information
 Table 136. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Description and Business Overview
 Table 137. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Product
 Table 139. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments/Updates
 Table 140. Disha Pharmaceutical Group Co., Ltd Company Information
 Table 141. Disha Pharmaceutical Group Co., Ltd Description and Business Overview
 Table 142. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Product
 Table 144. Disha Pharmaceutical Group Co., Ltd Recent Developments/Updates
 Table 145. Xian Janssen Pharmaceutical Ltd Company Information
 Table 146. Xian Janssen Pharmaceutical Ltd Description and Business Overview
 Table 147. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Product
 Table 149. Xian Janssen Pharmaceutical Ltd Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Gastric Motility Drugs Distributors List
 Table 153. Gastric Motility Drugs Customers List
 Table 154. Gastric Motility Drugs Market Trends
 Table 155. Gastric Motility Drugs Market Drivers
 Table 156. Gastric Motility Drugs Market Challenges
 Table 157. Gastric Motility Drugs Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastric Motility Drugs
 Figure 2. Global Gastric Motility Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastric Motility Drugs Market Share by Type: 2024 & 2031
 Figure 4. Monotherapy Product Picture
 Figure 5. Poly Pill Product Picture
 Figure 6. Global Gastric Motility Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gastric Motility Drugs Market Share by Application: 2024 & 2031
 Figure 8. Chronic Gastritis
 Figure 9. Reflux Esophagitis
 Figure 10. Functional Dyspepsia
 Figure 11. Others
 Figure 12. Global Gastric Motility Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Gastric Motility Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Gastric Motility Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Gastric Motility Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Gastric Motility Drugs Report Years Considered
 Figure 17. Gastric Motility Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Gastric Motility Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Gastric Motility Drugs Players: Market Share by Revenue in Gastric Motility Drugs in 2024
 Figure 20. Gastric Motility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Gastric Motility Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Gastric Motility Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Gastric Motility Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Gastric Motility Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Gastric Motility Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Gastric Motility Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Gastric Motility Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Gastric Motility Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Gastric Motility Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Gastric Motility Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Gastric Motility Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Gastric Motility Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Gastric Motility Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Gastric Motility Drugs by Type (2020-2031)
 Figure 54. Global Gastric Motility Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Gastric Motility Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Gastric Motility Drugs by Application (2020-2031)
 Figure 57. Global Gastric Motility Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Gastric Motility Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Gastrointestinal Motility Drugs Market Research Report 2024
Global Prokinetic Drug Market Insights Forecast to 2030
Global Gastric Antisecretory Drug Market Insights Forecast to 2030
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastric Volvulus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Idiopathic Gastroparesis Drugs Market Insights Forecast to 2030
Gastroesophageal Reflux Drugs Market
Global Gastroparesis Treatment Products Market Insights Forecast to 2030
Gastric Carcinomas Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digestive Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastroesophageal Reflux Disease GERD Drugs and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastroparesis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Gastritis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastric Pump Market Research Report 2025
Gastroesophageal Reflux Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Gastritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stomach Cancer Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions